| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism MMP2 inhibitors(Matrix metalloproteinase-2 inhibitors), MMP9 inhibitors(Matrix metalloproteinase 9 inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neuralgia | Phase 2 | Russia  | - | |
| Neuralgia | Phase 1 | - | - | 





